Ana sayfa Ürünler Tıbbi Test Malzemeleri

HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity

Name: HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity
Brand: Sichuan Hundred Medcal Technology Co., Ltd.
SKU: /
Availability: InStock

Tüm ürünler

Evde Kullanılan Tıbbi Cihaz
(42)

Tıbbi koruyucu malzemeler
(13)

Tıbbi diş cihazı
(23)

Cerrahi Sarf Malzemeleri
(35)

Tıbbi Analizci
(12)

Tıbbi Test Malzemeleri
(19)

tıbbi teşhis ekipmanları
(41)

Acil Kurtarma Ekipmanları
(13)

Solunum terapisi ekipmanları
(5)

tıbbi izleme ekipmanı
(10)

Tıbbi Sağlık Ürünleri
(25)

Yara Bakım Malzemeleri
(6)

Tıbbi sterilizasyon ekipmanları
(1)

Rehabilitasyon Tıbbi Ekipmanları
(14)

Hiperbarik ekipman
(2)

Sertifika

Ben sohbet şimdi

HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity

Büyük resim : HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity

Ürün ayrıntıları:

Menşe yeri:	Çin
Marka adı:	HDRMEDICO
Sertifika:	CE
Model numarası:	/

Ödeme & teslimat koşulları:

Min sipariş miktarı:	500 adet
Fiyat:	Pazarlık edilebilir
Ambalaj bilgileri:	karton
Teslim süresi:	10-15 gün
Ödeme koşulları:	L/C, T/T, Westen Union, Para Gramı, PayPal/VTB
Yetenek temini:	100000PC/Ay

İletişim Şimdi konuşalım.

HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity

Açıklama

Ürün Adı:	HIV-1/HIV-2/HIV-O Hızlı Testi	Malzeme:	Plastik
Ürün Kategorisi:	In vitro tanı	Test süresi:	15 dakika
Raf ömrü:	İki yıl	İşlev:	Bulaşıcı hastalık tespiti
Vurgulamak:	15-minute test duration HIV Rapid Test , Multi-type detection HIV Antibody Test , High sensitivity and specificity HIV-1/HIV-2/HIV-O Test

HIV-1/HIV-2/HIV-O Rapid Test All-Group HIV Antibody Test

The HIV-1/HIV-2/HIV-O Rapid Test is an advanced diagnostic reagent utilizing rapid immunochromatographic technology for qualitative detection of Human Immunodeficiency Virus (HIV) antibodies and antigens in human blood samples including whole blood, serum, or plasma. This comprehensive test simultaneously differentiates infections caused by HIV-1, HIV-2, and HIV-O (Group O) subtypes, providing critical information for early screening and viral typing.

Core Detection Capabilities:

The reagent employs multi-antibody coating technology to simultaneously detect:

HIV-1 Antibodies/Antigens: Covers major epidemic subtypes including Group M and rare variants
HIV-2 Antibodies: Specifically detects HIV-2 infection while avoiding cross-reactivity with HIV-1
HIV-O Antibodies: Designed for Group O strains, addressing potential missed detection by traditional reagents

Application Scenarios:

Suitable for various healthcare settings including medical institutions, disease control centers, blood donation sites, and emergency screening scenarios:

Early screening and typing confirmation in high-risk populations
Blood safety testing prior to donation procedures
Epidemiological surveys and strain monitoring programs

Technical Features of HIV-1/HIV-2/HIV-O Rapid Test:

High Sensitivity and Specificity: Utilizes combined detection strategy with recombinant antigens and monoclonal antibodies for reliable detection even in low-concentration samples
Rapid Results: Readable within 15-20 minutes without specialized equipment requirements
Simplified Operation: Supports direct testing with whole blood, minimizing sample pre-processing steps
Room Temperature Stability: Reagent can be stored and transported at ambient temperature conditions

Result Interpretation:

Positive results require confirmation via Western Blot (WB) or nucleic acid tests. Typing indications provide valuable guidance for subsequent viral load testing and treatment strategy selection.

Clinical Value of HIV-1/HIV-2/HIV-O Rapid Test:

Preliminary HIV typing through a single test significantly improves detection efficiency, particularly for precise prevention and control in regions where HIV-2 and Group O strains are prevalent. Typing information aids in optimizing antiviral treatment strategies and provides essential data support for public health surveillance.

Important Note: This product is intended for screening purposes only and must not be used as a definitive diagnostic tool. All operations must strictly follow established biosafety protocols. Positive samples should be reported according to regulatory requirements and forwarded to confirmation laboratories for further testing.

Etiket:

İlgili kişi: Mr. Terry

Tel: 15008220675

Diğer ürünler